Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer

BACKGROUND: Tumor necrosis factor (TNF) has been investigated to be correlated with the occurrence and progression of lung cancer. This investigation was to assess the efficacy and safety of recombinant mutant human tumor necrosis factor (rmhTNF) for controlling malignant pleural effusion (MPE) thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Tian, Lin, Yong, Zeng, Qingdi, Yao, Wei, Han, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301477/
https://www.ncbi.nlm.nih.gov/pubmed/32552897
http://dx.doi.org/10.1186/s12890-020-01210-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301477/
https://www.ncbi.nlm.nih.gov/pubmed/32552897
http://dx.doi.org/10.1186/s12890-020-01210-x

Ejemplares similares